Cellebrite: A Rare SaaS Play Where AI Is A Tailwind, Not A Threat

Cellebrite DI operates in a niche with strong regulatory moats, high switching costs, and robust customer entrenchment. CLBT's financials are solid: subscription revenue up 21%, ARR at $481M, Rule of 40 above 55, and FCF margin at 34%. AI integration enhances CLBT's value proposition, accelerating evidence discovery and reinforcing its competitive positioning and growth prospects.